The Health Tech World Podcast is back with an all-new series.
The podcast focuses on all aspects of new and future healthcare tech, backed by a team of specialist journalists, experts and analysts.
In the first episode of the new series, Dr Peter Hamley addresses the hype around Alzheimer’s drug donanemab and reveals how Samsara Therapeutics is harnessing autophagy to tackle neurodegenerative disease.
More episodes are set to be published in the coming weeks, addressing a wide range of healthcare and health tech topics.
Listen and subscribe to the Health Tech World podcast on Spotify here
